News
research-laboratory-hero-image
Friday 24 October 2014
In today’s news, you may have read or heard about the drug olaparib receiving a recommendation from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use. Olaparib is one of several PARP inhibitor drugs that are currently being trialled, which reduce the ability of...
News
research-laboratory-hero-image
Thursday 16 October 2014
In the news today, researchers have devised a new test to help doctors classify ovarian cancer tumours and choose the most appropriate treatment. Successful treatment of ovarian cancer depends in part on accurately identifying the type of tumour, but this can be difficult. As a result, many women...
News
Walk-for-one-million-2014
Wednesday 15 October 2014
Over 300 walkers pulled on their boots and completed the 10km route at the two Walk for One Million events in Scotland and England earlier this month. The flagship fundraising and awareness event returned to Hatfield House for the second time, marking the third year the event had been held in...
News
Annie Mulholland
Wednesday 8 October 2014
Inequalities in access to life-changing drugs have been a topic in the news this week. With limited treatment options for ovarian cancer, Target Ovarian Cancer has long been campaigning to ensure that women in England, Northern Ireland, Scotland and Wales can access those drugs that are showing a...

Pages